Tom Schulz

8PUBLICATIONS
46CO-AUTHORS
Molecular targetsGene and molecular therapyPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 06, 2026
Structure-based scaffold hopping reveals strategies to overcome oncogenic KIT and PDGFRA mutation-driven drug-resistance in GIST.

|Mar 02, 2026
Lessons from Structural Biology for Understanding Drug Resistance in Gastrointestinal Stromal Tumors (GIST).

Giorgia Mancino, Tom Schulz, Andrea Scrima

|Jul 29, 2025
Phase II Trial of Ponatinib in Patients with Metastatic Gastrointestinal Stromal Tumor following Failure or Intolerance of Prior Therapy with Imatinib (POETIG Trial).

Johanna Falkenhorst, Philipp Ivanyi, Tom Schulz

|May 14, 2025
Advancing TET Inhibitor Development: From Structural Insights to Biological Evaluation.

Suzanne Willems, Lejla Maksumic, Janina Niggenaber

|Jan 22, 2025
Design, Synthesis, and SAR of Covalent KIT and PDGFRA Inhibitors─Exploring Their Potential in Targeting GIST.

Tom Schulz, Rajesh Gontla, Alina Teuber

|Feb 26, 2024
KIT ATP-Binding Pocket/Activation Loop Mutations in GI Stromal Tumor: Emerging Mechanisms of Kinase Inhibitor Escape.

Thomas Mühlenberg, Johanna Falkenhorst, Tom Schulz

Pageof 2

Frequent Collaborators

8 joint publications

Daniel Rauh

6 joint publications

Matthias P Müller

4 joint publications

Alina Teuber

4 joint publications

Thomas Mühlenberg